Semaglutide is selling like crazy 💸 The parent company of Semaglutide, Novo Nordisk, just released their 2025 annual financial report, and it's basically a money printing machine: total sales amounting to approximately 250.8 billion RMB. Currently, the only competitor that can shake its position globally is Eli Lilly's "Tirzepatide." The battle for pharmaceutical dominance between the two giants has already heated up. Tirzepatide sold $24.8 billion in the first three quarters of last year. After the full-year data is released, it's hard to say who will be the new "King of All Drugs." Interestingly, right after these two miracle weight-loss drugs hit the market, many internet celebrities and entertainment stars announced their success with "dieting and exercise" 😂. It must be said that weight management is truly a trillion-dollar super-urgent market.